Causes of acute paraparesis

Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
I now have comprehensive material from multiple authoritative textbooks. Let me synthesize this into a well-organized answer.

Causes of Acute Paraparesis

Acute paraparesis (sudden-onset bilateral leg weakness) is a neurological emergency. The causes are best organized by anatomical level and mechanism.

Localizing the Level First

Before categorizing causes, the clinical pattern guides localization:
FeatureSuggests
Flaccid legs, areflexia, sensory levelSpinal cord (acute "spinal shock" phase)
Flaccid legs, areflexia, no sensory levelCauda equina or peripheral nerve/muscle
Spastic legs, sensory levelSpinal cord (UMN)
Sphincter involvementSpinal cord or cauda equina
Dissociated sensory loss (pain/temp ↓, proprioception preserved)Anterior cord syndrome

I. Spinal Cord Causes (Most Common)

A. Compressive / Extrinsic

CauseKey Features
Spinal epidural abscessFever, back pain, progressive neurological deficit; percussion tenderness; MRI confirms; emergency decompression + IV antibiotics
Spinal epidural hematomaSudden severe radicular pain → weakness; associated with anticoagulation, trauma, coagulopathy, lumbar puncture; treat with surgical decompression
Acute disc herniation (midline, thoracic/cervical)Acute cord compression; trauma or spontaneous
Metastatic spinal cord compressionNight pain worse lying flat; known or occult malignancy (breast, lung, prostate, myeloma); MRI urgent
Atlanto-axial subluxationRheumatoid arthritis, Down syndrome, trauma
Acute spondylotic myelopathyHyperextension injury on background of cervical spondylosis; pre-existing canal stenosis; ligamentum flavum buckling
Subdural hematoma / empyemaRare; similar presentation to epidural

B. Intrinsic / Noncompressive — Vascular

CauseKey Features
Spinal cord infarction (anterior spinal artery syndrome)Hyperacute onset; paraplegia/paraparesis + spinothalamic loss (pain & temp ↓) with preserved dorsal columns (proprioception intact); causes include aortic atherosclerosis, aortic dissection, aortic surgery, vertebral artery dissection/occlusion, cardiogenic emboli, vasculitis, profound hypotension; MRI brain negative for bilateral ACA infarcts
Spinal AVM / arteriovenous fistulaDural AVF most common in older men; stepwise or acute myelopathy
Hematomyelia (intramedullary hemorrhage)Acute painful transverse myelopathy; causes: trauma, vascular malformation, vasculitis (polyarteritis nodosa, SLE), bleeding disorders, cord neoplasm
Spinal subarachnoid hemorrhageFocal deficits at bleed level, headache possible; MRI ± LP

C. Intrinsic / Noncompressive — Inflammatory / Demyelinating

CauseKey Features
Acute transverse myelitis (idiopathic)Paraplegia + sensory level + sphincter dysfunction; follows viral illness in ~30%; thoracic cord in 60–70%; MRI T2 signal change ± enhancement
Multiple sclerosisPartial or complete cord syndrome; relapsing history; MRI shows other lesions; CSF oligoclonal bands
Neuromyelitis optica spectrum disorder (NMOSD)Anti-AQP4 or anti-MOG antibodies; longitudinally extensive lesion (≥3 segments); often severe
SarcoidosisMultisystem involvement; serum ACE, chest CT, biopsy
Systemic lupus erythematosus (SLE)Myelopathy in known or new SLE; antiphospholipid syndrome overlap
Behçet's diseaseOrogenital ulcers, uveitis; brainstem/cord involvement
Acute disseminated encephalomyelitis (ADEM)Post-infectious/post-vaccination; multifocal CNS; commoner in children

D. Intrinsic / Noncompressive — Infectious

CauseKey Features
Viral myelitis — HSV-2, VZV, EBV, CMV, enterovirus, HIV, HHV-6CSF PCR; HIV myelopathy in advanced disease
HTLV-1 myelopathy (tropical spastic paraparesis)Subacute > acute; endemic regions; serology
West Nile virusAcute flaccid paralysis (anterior horn cells); fever, encephalitis possible
PoliomyelitisAcute flaccid paraparesis; anterior horn cell
SchistosomiasisEndemic areas; lumbosacral cord; granulomatous myelitis
NeurosyphilisMeningovascular; CSF VDRL
Lyme diseaseBorrelia; radiculomyelopathy
Tuberculous myelitis / Pott's diseaseVertebral destruction, epidural spread; endemic setting

II. Cauda Equina / Conus Medullaris

These produce lower motor neuron weakness (flaccid, areflexic) with saddle anaesthesia and prominent sphincter involvement:
  • Massive midline lumbar disc prolapse — most common; acute back pain + bilateral leg weakness + urinary retention
  • Cauda equina tumor (ependymoma, schwannoma, meningioma)
  • Lumbosacral trauma
  • HIV-related acute lumbosacral polyradiculopathy (CMV in immunocompromised)
  • Spinal epidural abscess/hematoma at lumbar level

III. Cerebral / Supratentorial Causes (Rare)

Bilateral leg weakness with upper motor neuron signs but no sensory level:
CauseKey Features
Bilateral ACA territory infarctionShoulder shrug (shoulder abduction) also affected
Superior sagittal sinus / cortical venous thrombosisHeadache, seizures, bilateral leg weakness from parasagittal involvement
Acute hydrocephalusBilateral leg weakness (stretching of periventricular fibers)
Parasagittal meningiomaMore subacute; bilateral leg signs

IV. Peripheral / Neuromuscular Causes

Can mimic paraparesis if bilateral and severe — absence of sensory level and UMN signs distinguishes:
CauseFeatures
Guillain-Barré syndromeAscending flaccid areflexic weakness; albuminocytologic dissociation in CSF
Acute anterior horn cell disease — Polio, West NileFever + asymmetric flaccid paralysis
Myopathy / periodic paralysisMetabolic (K⁺, Ca²⁺, phosphate, Mg²⁺ disturbances); no sensory loss; no reflexes lost early
Toxic myopathy / botulismDescending paralysis (botulism); rhabdomyolysis

Approach Summary

Acute paraparesis
     ├── Sensory level / UMN signs → Spinal cord MRI STAT
     │        ├── Compressive? → Surgery/Antibiotics emergency
     │        └── Noncompressive? → LP + autoimmune/infectious workup
     ├── No sensory level, flaccid/areflexic → Cauda equina vs. GBS vs. myopathy
     └── Bilateral leg UMN + brain signs → Brain MRI (ACA infarct, SST)
MRI spine with contrast is the investigation of first choice in all cases where a spinal cord lesion is suspected. LP for CSF analysis follows once cord compression is excluded.

Sources: Harrison's Principles of Internal Medicine 22E (2025); Rosen's Emergency Medicine 10E; Bradley and Daroff's Neurology in Clinical Practice; Adams and Victor's Principles of Neurology 12E

55 Yr 2 episode of seizures and altered sensorium approach to pt .. history and examination

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Loading Image
I now have comprehensive, textbook-level material. Let me compile the full structured answer.

Approach to a 55-Year-Old with 2 Episodes of Seizures + Altered Sensorium

A 55-year-old presenting with new-onset seizures and altered sensorium is a neurological emergency until proven otherwise. In this age group (35–64 years), cerebrovascular disease is the single most common cause (~35%), followed by tumors (~24%), trauma (~22%), and metabolic/toxic causes. The altered sensorium adds urgency — it suggests either ongoing postictal state, status epilepticus, structural brain injury, meningoencephalitis, or a metabolic encephalopathy.
Causes of Seizure by Age Group

Step 1 — Initial Stabilization (Before History)

ABC + rapid bedside assessment:
  • Airway, breathing, circulation
  • Capillary blood glucose immediately (hypoglycemia is the most treatable cause)
  • IV access, pulse oximetry, cardiac monitor
  • GCS score
  • Is the patient still seizing? → If so, manage as status epilepticus

Step 2 — HISTORY

A. Confirm It Was a Seizure (Not a Mimic)

From witness (paramount):
  • Onset: sudden or gradual?
  • Type of movements: tonic? clonic? tonic-clonic? focal limb jerking? head/eye deviation?
  • Duration of episode (exact)
  • Was there a cry/vocalization at onset?
  • Did the patient fall? Sustain injury?
  • Skin color: cyanosis, pallor?
  • Loss of consciousness: complete or partial?
  • Tongue biting (lateral tongue bite → seizure; tip bite → syncope)
  • Incontinence (urinary/fecal)
  • Post-episode behavior: confusion, drowsiness, Todd's paralysis, headache, amnesia?
Mimics to exclude:
  • Syncope (preceded by prodrome — nausea, diaphoresis, pallor; recovery rapid)
  • Cardiac arrhythmia (ventricular tachycardia; palpitations; ECG abnormality)
  • TIA (loss of function, not spreading excitation; no post-ictal confusion)
  • Hypoglycemic episode
  • Psychogenic non-epileptic seizures (PNES)
  • Migraine with aura

B. Characterize the Seizure Type

  • Focal onset (aware or impaired awareness) vs. generalized → critical for workup
  • Any aura beforehand? Olfactory, gustatory, déjà vu, rising epigastric feeling → temporal lobe
  • Visual/sensory aura → occipital/parietal
  • Second episode — same or different semiology? What interval?
  • Did patient have eye/head deviation at onset? → indicates contralateral frontal focus

C. History of Present Illness

  • Fever, headache, neck stiffness, photophobia → meningoencephalitis (urgent)
  • Headache (progressive, worse lying flat) → raised ICP, SOL
  • Focal weakness, speech disturbance, vision change → structural lesion
  • Vomiting → raised ICP
  • Recent head trauma (even trivial) → subdural/extradural hematoma
  • Altered behavior/personality change over weeks → tumor, encephalitis (autoimmune/viral)
  • Fever + rash → HSV encephalitis, bacterial meningitis, CNS vasculitis
  • Polyuria, polydipsia → hypo-/hyperglycemia, hyponatremia
  • Recent illness / vaccination → ADEM
  • Recent travel → neurocysticercosis (endemic areas), cerebral malaria, TB
  • Timeline of altered sensorium relative to seizures

D. Past Medical History

Ask aboutRelevance
Hypertension, diabetes, CAD, atrial fibrillationStroke, hypertensive encephalopathy
Prior stroke, TIACortical scar → epileptic focus
Known malignancy (breast, lung, colon, kidney, melanoma)Cerebral metastasis
HIV, immunocompromiseCNS lymphoma, CMV, toxoplasmosis, TB, cryptococcal
Liver disease (cirrhosis, hepatitis)Hepatic encephalopathy
Renal diseaseUremic encephalopathy, hyponatremia
Thyroid diseaseHashimoto's encephalopathy; hypo/hyperthyroidism
Autoimmune disease (SLE, vasculitis)CNS vasculitis
Prior seizures in childhood (febrile convulsions)Lowers threshold
Prior brain surgery or CNS infectionScar epilepsy

E. Drug and Substance History

Ask aboutRelevance
Alcohol history — amount, last drinkWithdrawal seizures (48–72 h after cessation)
Benzodiazepines, barbiturates — recent reduction/stopWithdrawal
Recreational drugs (cocaine, amphetamines)Provoked seizures
Prescribed medicationsProconvulsant drugs (tramadol, tricyclics, fluoroquinolones, isoniazid, theophylline, lithium, clozapine)
Recent change in antiepileptic drug (AED)Sub-therapeutic levels
Herbal / traditional medicinesCNS toxicity

F. Family and Social History

  • Family history of epilepsy
  • Occupation (driver? — implications for treatment)
  • Lives alone?
  • Sleep deprivation, extreme physical or emotional stress

Step 3 — EXAMINATION

General Examination

SignSuggests
FeverMeningoencephalitis, brain abscess, septic encephalopathy
High BP (>180/120)Hypertensive encephalopathy, posterior reversible encephalopathy syndrome (PRES)
Low BPSepsis, cardiogenic cause, Addisonian crisis
TachycardiaCardiac arrhythmia, sepsis, thyroid storm
Cyanosis / low SpO₂Hypoxic seizure
PallorAnaemia, blood loss (subdural hematoma)
JaundiceHepatic encephalopathy
Stigmata of chronic liver diseaseHepatic encephalopathy
LymphadenopathyLymphoma, malignancy, TB
Skin rashMeningococcal purpura, SLE, HSV, neurofibromatosis, tuberous sclerosis
Head trauma signs: Battle's sign, raccoon eyes, haemotympanum, CSF leakBase of skull fracture → intracranial bleed
Tongue laceration (lateral)Confirms seizure
Incontinence signs
Needle marks / drug track marksSubstance abuse

Neurological Examination (Systematic)

1. Level of Consciousness & Cognition

  • GCS (E+V+M) — document precisely
  • MMSE / orientation — time, place, person
  • Is this true postictal drowsiness or new encephalopathy?
  • Postictal state: usually improves steadily over 20–60 min; persisting confusion → structural/metabolic

2. Meningeal Signs

  • Neck stiffness (Kernig's sign, Brudzinski's sign) → meningitis, SAH, encephalitis
  • Note: may be absent in immunocompromised / elderly

3. Cranial Nerves

CNWhat to look for
CN IIPapilloedema (raised ICP), visual field defect
CN III, IV, VIPupil asymmetry (herniation!), gaze palsy, VI palsy (false localizing, raised ICP)
CN VIIFacial asymmetry → frontal lobe lesion (contralateral)
CN XIITongue deviation

4. Motor System

  • Focal weakness → contralateral structural lesion
  • Todd's paralysis — transient hemiparesis after focal seizure (30 min – 36 h); clears spontaneously
  • Tone: hypotonia (metabolic/toxic), spasticity (structural)
  • Pronator drift
  • Plantar response (upgoing Babinski → UMN lesion or postictal)

5. Sensory System

  • Hemisensory loss → contralateral parietal lesion

6. Cerebellar

  • Ataxia, nystagmus → posterior fossa lesion, drug toxicity (phenytoin, carbamazepine)

7. Deep Tendon Reflexes

  • Hyperreflexia + Babinski → UMN lesion
  • Hyporeflexia → metabolic, drug effect

8. Fundoscopy (MANDATORY)

  • Papilloedema → raised ICP → LP contraindicated before imaging

Differential Diagnosis Framework (55-Year-Old)

Seizures + Altered Sensorium at 55 yrs
│
├── STRUCTURAL (most common in this age)
│    ├── Stroke (ischemic / hemorrhagic)
│    ├── Subdural / extradural hematoma
│    ├── Brain tumor (primary glioma or metastasis)
│    └── Brain abscess / granuloma (TB, NCC)
│
├── METABOLIC / SYSTEMIC
│    ├── Hypo/hyperglycemia
│    ├── Hyponatremia (Na⁺ <125 mEq/L)
│    ├── Uremic encephalopathy
│    ├── Hepatic encephalopathy
│    ├── Hypocalcemia / hypomagnesemia
│    ├── Hypoxia / hypercapnia
│    └── Hypertensive encephalopathy / PRES
│
├── INFECTIVE / INFLAMMATORY
│    ├── Bacterial meningitis
│    ├── Viral encephalitis (HSV most important)
│    ├── Autoimmune encephalitis (anti-NMDAR, LGI1, CASPR2)
│    ├── TB meningoencephalitis
│    └── Cerebral malaria / neurocysticercosis
│
├── TOXIC / DRUG
│    ├── Alcohol withdrawal (48–72 h after last drink)
│    ├── Benzodiazepine/barbiturate withdrawal
│    └── Drug toxicity (proconvulsants)
│
└── VASCULAR
     └── Cerebral venous sinus thrombosis (CVST)

Red Flags Demanding Immediate Action

Red FlagAction
Fever + meningismLP after imaging → treat empirically for bacterial meningitis + HSV encephalitis BEFORE LP
Focal deficits / papilloedemaCT brain before LP
Ongoing altered sensorium >30 min post-seizureRule out non-convulsive status epilepticus → urgent EEG
Severe hypertension + encephalopathyTreat as PRES / hypertensive emergency
Known malignancyMRI with contrast
Anticoagulated / alcoholic / elderlyExclude intracranial bleed
Glucose < 3 mmol/LIV dextrose immediately

Sources: Adams and Victor's Principles of Neurology 12E; Harrison's Principles of Internal Medicine 22E; Bradley and Daroff's Neurology in Clinical Practice

25 Yr female with wasting of left hand wasting with motor weakness 3 month without sensory involved Differential

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Excellent — rich data from multiple authoritative sources. Let me now compose the full structured differential.

25-Year-Old Female: Left Hand Wasting + Pure Motor Weakness (3 months, No Sensory Loss)

Key Diagnostic Features to Lock In

The clinical signature here is:
  • Young female, 25 years
  • Unilateral (left hand)
  • Wasting + weakness (lower motor neuron pattern — flaccid, ± fasciculations, ± hyporeflexia)
  • 3 months — subacute/chronic, not acute
  • No sensory loss — this is the critical differentiating feature
The absence of sensory involvement localizes the pathology to structures that carry only motor fibers — anterior horn cells, motor roots, motor division of peripheral nerves — or to intrinsic cord lesions that selectively damage anterior horn cells (with sensory fibers initially spared).

Localization First

LevelPatternSensory
Anterior horn cellPure LMN wasting, fasciculations, no sensoryAbsent (pure motor cells)
Anterior root (motor root)Pure LMN, segmental distributionAbsent
Intrinsic cord (syrinx, early)Dissociated sensory loss + LMN at levelMay be absent early
Lower trunk / medial cord brachial plexusC8-T1 wastingUsually some sensory in medial forearm/hand
Pure motor peripheral nerveDeep palmar ulnar, posterior interosseousNo sensory
MuscleWasting without reflex change earlyNo sensory

Differential Diagnosis (Most Likely to Least in This Patient)

1. Hirayama Disease (Benign Monomelic Amyotrophy / Juvenile Segmental Muscular Atrophy) ⭐ TOP DIAGNOSIS

"The most common presentation is one of an idiopathic, slowly progressive, painless weakness and atrophy in one hand or forearm... The condition remains limited to only a few myotomes." — Bradley and Daroff's Neurology
Why top diagnosis:
  • Classic age of onset: teens to early 30s
  • More common in women in Indian subcontinent (though 60% are male overall)
  • Predominantly C7–T1 myotomes → intrinsic hand muscles + forearm
  • "Oblique atrophy" pattern — thenar, hypothenar, interossei wasted; brachioradialis spared
  • Pure LMN, no sensory loss, no UMN signs, no cranial nerve involvement
  • Painless, slow progression over 2–3 years then stabilizes
  • Proposed mechanism: dynamic cord compression during neck flexion (disproportionate dural sac growth)
  • EMG: active and chronic denervation at C7–T1; NCS show reduced CMAPs, near-normal SNAPs
  • MRI cervical spine (dynamic — flexion views): flattening of anterior cord, loss of attachment of posterior dura, asymmetric cord atrophy

2. Cervical Myelopathy — Syringomyelia

"Syringomyelia... damage to the fibers crossing in the anterior commissure destined for the spinothalamic tract... By the time descending tracts are affected, segmental motoneuron and corticospinal tract damage are almost always present." — Bradley and Daroff's
Features:
  • Syrinx classically causes cape-like dissociated sensory loss (pain/temp lost, proprioception preserved)
  • However, early syrinx can present with pure hand wasting (anterior horn cell damage at the level of the syrinx) before sensory fibres are involved
  • Associated with Chiari malformation (Type I most common), trauma, tumors, arachnoiditis
  • May later develop UMN signs in legs (descending tract involvement)
  • 25-year-old female + no sensory involvement yet → must exclude with MRI
  • MRI spine: T2 fluid-filled cavity within cord over multiple segments

3. True Neurogenic Thoracic Outlet Syndrome (TOS)

"True neurogenic TOS... compression of the lower trunk (C8/T1)... weakness and wasting of intrinsic muscles of the hand and diminished sensation on the palmar aspect of the fifth digit." — Harrison's Principles
Features:
  • Caused by anomalous fibrocartilaginous band from elongated C7 transverse process (cervical rib) to first rib
  • C8/T1 compression → hand intrinsic wasting
  • Pain is mild or absent — can initially appear as pure motor
  • Sensory loss on 5th digit/medial forearm — may be minimal or absent early
  • Young women, often exacerbated by arm position
  • CXR: elongated C7 transverse process / cervical rib
  • EMG/NCS: reduced SNAP medial forearm, low CMAP ulnar > median
  • Treatment: surgical band resection (wasting usually does not recover but progression halts)

4. Multifocal Motor Neuropathy (MMN) with Conduction Block

"Pure LMN involvement... enters the differential diagnosis of benign focal amyotrophy and the PMA variant of ALS. It is important to search for this since it is treatable." — Bradley and Daroff's
Features:
  • Autoimmune; anti-GM1 antibodies in ~50%
  • Asymmetric, pure motor — starts distally, upper > lower limbs
  • No sensory loss (distinguishes from CIDP)
  • Fasciculations may be present
  • Can begin with focal hand wasting in a young adult
  • EMG/NCS: focal conduction block outside carpal tunnel → pathognomonic
  • Treatable — high-dose IVIG; this makes the diagnosis essential to establish
  • CK mildly elevated; anti-GM1 IgM elevated

5. Compressive Focal Motor Neuropathy

Pure motor syndromes can arise from compression of purely motor nerve branches:
Nerve CompressedPattern
Deep palmar branch of ulnar nerve (at Guyon's canal — motor division)Hypothenar + interossei wasting; no sensory loss
Posterior interosseous nerve (radial nerve deep branch)Wrist/finger extension weakness; no sensory loss
Anterior interosseous nerveLoss of pinch (FPL + FDP index); no sensory loss
  • Relevant in occupational/repetitive trauma
  • EMG/NCS confirms level and type

6. Cervical Radiculopathy — C8/T1 Root (Predominantly Motor)

Features:
  • Disc prolapse or osteophyte compressing C8 or T1 motor root
  • Can produce hand intrinsic weakness and wasting
  • Sensory involvement is typical but can be minimal or overlooked
  • C8: ring/little finger, medial forearm sensory if affected; intrinsic + FDP weakness
  • T1: intrinsic hand muscles (abductor pollicis brevis, interossei)
  • MRI cervical spine confirms
  • 25-year-old: less common but possible (disc herniation)

7. Pancoast Tumor (Superior Sulcus Tumor)

Features:
  • Lung apex tumor invading lower brachial plexus (C8/T1)
  • Progressive hand intrinsic wasting
  • Horner's syndrome (ptosis, miosis, anhidrosis) — highly specific association
  • Usually painful (shoulder/arm pain)
  • Sensory involvement of medial forearm/hand expected
  • 25-year-old female: rare but must not miss — especially if smoker
  • CXR, CT thorax, MRI brachial plexus

8. Lower Brachial Plexopathy — Other Causes

  • Radiation plexopathy (prior radiotherapy)
  • Neoplastic infiltration (lymphoma, metastasis — less likely at 25)
  • Neuralgic amyotrophy (Parsonage-Turner syndrome) — usually starts with severe pain, then weakness; sensory loss usually follows

9. Spinal Muscular Atrophy (SMA) — Adult Onset

Features:
  • SMA Type III (Kugelberg-Welander) / Type IV: onset in adulthood possible
  • Pure LMN, symmetric or asymmetric, no sensory loss
  • Proximal > distal typically, but distal hand involvement can occur
  • Slowly progressive
  • Genetic: SMN1 deletion/mutation
  • Creatine kinase may be elevated

10. Monomelic Motor Neuropathy — Hereditary (CMT Variants)

  • Charcot-Marie-Tooth (CMT) — usually bilateral, but rare asymmetric presentations
  • Distal hereditary motor neuropathy (dHMN): pure motor, distal wasting, no sensory loss
  • Family history may be absent in sporadic cases
  • Nerve conduction/genetic testing

Less Likely in a 25-Year-Old Female (but to Exclude)

ConditionReason to list
ALSVery unlikely at 25, usually absent UMN signs in early hand-onset PMA variant; rule out
Lead poisoningPure motor neuropathy; radial nerve ("wrist drop"); occupational exposure
PorphyriaAcute intermittent porphyria → pure motor neuropathy; episodic; urine porphyrins
Inclusion body myositisOlder patients; long finger flexors + quadriceps; CK elevated
Focal myositisRare; MRI muscle

Summary Table

DiagnosisPure Motor?Age / SexKey FeatureInvestigation
Hirayama diseaseYoung adult, FOblique atrophy, stabilizes, neck flexion aggravatesCervical MRI (flexion views), EMG
Syringomyelia✅ earlyYoung adultDissociated sensory loss (may be absent early), ChiariMRI spine
Neurogenic TOSYoung femaleCervical rib, C7 transverse processCXR, NCS, EMG
MMNAny ageConduction block, anti-GM1NCS (conduction block), anti-GM1
Deep palmar ulnar neuropathyAnyMotor-only branch compressionNCS, EMG
C8/T1 radiculopathyMostlyAnyDisc prolapseMRI cervical spine
Pancoast tumor±AnyHorner's, shoulder painCXR, CT thorax
SMA adultAnySMN1 mutationGenetic testing, EMG
dHMNYoungFamily history, bilateral eventuallyNCS, genetics

Priority Investigations

  1. MRI cervical spine (with dynamic flexion views if Hirayama suspected) — exclude syrinx, Chiari, cord atrophy, disc herniation
  2. EMG / Nerve conduction studies — localizes to anterior horn vs. root vs. plexus vs. peripheral nerve; identifies conduction block (MMN), characterizes denervation pattern
  3. Chest X-ray / CT thorax — cervical rib, Pancoast tumor
  4. Anti-GM1 IgM antibodies — MMN
  5. Genetic testing (SMN1, PMP22) — if SMA or CMT suspected
  6. Urine porphyrins — if episodic or occupational exposure
  7. Serum CK — elevated in myopathic or neurogenic conditions
  8. Blood lead levels — if occupational risk

Sources: Bradley and Daroff's Neurology in Clinical Practice; Harrison's Principles of Internal Medicine 22E; Goldman-Cecil Medicine

Unilateral with pure motor only

The previous answer already covered this — the case is unilateral (left hand only) and pure motor (no sensory). Let me sharpen the differential specifically around that constraint and rank it more tightly.

Unilateral Hand Wasting — Pure Motor Only (No Sensory)

The unilateral + pure motor combination is the key constraint. It eliminates most polyneuropathies and most metabolic/systemic causes. The lesion must be in a structure carrying motor signals exclusively or predominantly.

Anatomical Logic: Where Can a Purely Motor, Unilateral Lesion Sit?

Cortex / Corticospinal tract
    ↓  (UMN — wasting rare, no fasciculations)
Anterior Horn Cell  ←── Pure motor, unilateral = MOST SPECIFIC LEVEL
    ↓
Anterior (Motor) Root  ←── Pure motor if dorsal root spared
    ↓
Brachial Plexus lower trunk / medial cord
    ↓  (sensory usually co-involved, but minimal early)
Pure Motor Peripheral Nerve branch
    ↓  (deep palmar ulnar, AIN, PIN)
Muscle  ←── No sensory, but wasting pattern differs

The Focused Differential (Unilateral, Pure Motor, Young Female, Subacute)


1. ⭐ Hirayama Disease (Benign Monomelic Amyotrophy)

The single most likely diagnosis in this exact clinical scenario.
  • 25-year-old, unilateral hand/forearm wasting, pure LMN, no sensory loss, no UMN signs, no pain
  • C7–T1 anterior horn cell degeneration, confined to one limb
  • "Oblique atrophy" — all intrinsic hand muscles + forearm flexors wasted, brachioradialis spared (C5/6 — above the lesion)
  • Mini-polymyoclonus (finger tremor on extension) — characteristic
  • Progression over 2–3 years then arrests spontaneously
  • ♀ in Indian subcontinent: less gender bias than in Japan
  • No fasciculations at rest typically (distinguishes from ALS)
Investigations:
  • EMG: chronic + active denervation C7–T1, normal SNAPs
  • MRI cervical spine in neutral AND flexion: asymmetric cord atrophy, loss of posterior dural attachment, anterior displacement of posterior dura on flexion, intramedullary T2 signal at C5–C8

2. Syringomyelia (Early / Eccentric Syrinx)

  • An eccentric syrinx can selectively destroy one side's anterior horn cells before crossing fibres or dorsal columns are involved — producing unilateral pure motor wasting
  • Associated with Chiari I malformation (common in young women), post-traumatic, idiopathic
  • Sensory loss (dissociated — pain/temp only, cape distribution) typically follows later
  • Should always be excluded in any young person with unilateral hand wasting
  • MRI spine: T2 hyperintense CSF-filled cavity; look for tonsillar descent (Chiari)

3. Multifocal Motor Neuropathy (MMN)

  • Pure motor, asymmetric, distal upper limb onset — classic presentation
  • Mimics anterior horn cell disease but is demyelinating and treatable
  • No sensory loss (distinguishes it from CIDP)
  • Unilateral hand onset is well-described
  • Anti-GM1 IgM antibodies (~50%)
  • NCS: focal conduction block outside standard entrapment sites — pathognomonic
  • Responds to high-dose IVIG — critical not to miss

4. Pure Motor Focal Neuropathy (Compressive/Entrapment)

These are purely motor nerve branches — no sensory fibres:
NerveSiteMuscles WastedClue
Deep (motor) branch of ulnar nerveGuyon's canal (motor division only)Hypothenar, interossei, adductor pollicisNo sensory loss, occupational/cycle/crutch pressure
Anterior interosseous nerve (AIN)Proximal forearmFPL, FDP (index), pronator quadratus"Pinch sign" — can't make O with thumb+index
Posterior interosseous nerve (PIN)Radial tunnelFinger/wrist extensorsWrist drop without sensory loss
  • Deep ulnar motor branch = most relevant for intrinsic hand wasting without sensory loss
  • Cause: ganglion, repetitive pressure (cyclists, typists), occupational

5. Neurogenic Thoracic Outlet Syndrome (True TOS)

  • Anomalous fibrocartilaginous band, elongated C7 transverse process / cervical rib → compresses lower trunk (C8/T1)
  • Wasting of intrinsic hand muscles, predominantly motor
  • Sensory loss (medial forearm, 5th digit) is classically mild or absent — can appear pure motor
  • Young women are disproportionately affected
  • CXR: elongated C7 transverse process
  • NCS/EMG: reduced CMAP ulnar > median; reduced SNAP medial forearm (if sensory affected at all)

6. C8 or T1 Motor Root Compression (Radiculopathy — Motor Predominant)

  • Cervical disc herniation compressing C8 or T1 root
  • Dorsal (sensory) root can be spared if compression is purely anterior (ventral root lesion)
  • Hand intrinsic wasting (T1) or FDP/FPL weakness (C8)
  • Young adults: soft disc prolapse possible
  • MRI cervical spine confirms

7. Spinal Muscular Atrophy (SMA) — Focal / Asymmetric Variant

  • Adult-onset SMA (Type III/IV) or distal hereditary motor neuropathy (dHMN) can start asymmetrically
  • Pure LMN, no sensory loss — by definition
  • Family history may be absent
  • SMN1 gene testing; EMG shows widespread chronic denervation beyond clinically affected limb

8. Monomelic Amyotrophy Secondary to Intrinsic Cord Lesion

  • Intramedullary tumor (ependymoma, astrocytoma) at cervical cord level
  • Selective anterior horn involvement before sensory tracts affected
  • Rare but must be excluded with MRI

What Makes This NOT ALS

ALS is in the differential for any pure motor wasting, but in this patient:
FeatureThis PatientALS
Age25 ♀Usually >40
DistributionUnilateral hand, confinedSpreads relentlessly
UMN signsAbsentUsually present (brisk reflexes, Babinski)
BulbarAbsentDevelops
Progression3 months, stable handRelentless progression
FasciculationsNot mentionedWidespread
ALS remains a diagnosis of exclusion — all other treatable causes must be systematically ruled out before considering it.

Ranked Summary

RankDiagnosisKey Distinguishing Feature
1Hirayama diseaseYoung, oblique atrophy, arrests, dynamic MRI
2Syringomyelia (early eccentric)MRI cord signal, Chiari
3MMNConduction block on NCS, anti-GM1, treatable
4Deep ulnar motor branch neuropathyHypothenar + interossei only, occupational
5True neurogenic TOSCervical rib, C8/T1, young female
6C8/T1 radiculopathyMRI disc prolapse
7SMA / dHMNGenetic, EMG beyond affected limb
8Intramedullary tumorMRI cord

Minimum Workup

  1. MRI cervical spine — neutral + flexion (Hirayama), T2 (syrinx, Chiari, tumor, disc)
  2. EMG + NCS — pattern of denervation, conduction block, SNAP intact?
  3. Anti-GM1 IgM — MMN
  4. CXR — cervical rib / elongated C7 transverse process
  5. SMN1 gene test — if EMG shows widespread denervation beyond one limb
Sources: Bradley and Daroff's Neurology in Clinical Practice; Harrison's Principles of Internal Medicine 22E; Goldman-Cecil Medicine

Procide in case of meningitis with raised ict and how to collect csf in large hydrocephalus case

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
I have enough textbook material combined with core clinical knowledge. Let me give a comprehensive answer on both questions.

Procedure in Meningitis with Raised ICP + CSF Collection in Hydrocephalus

These are two related but distinct clinical problems that require precise decision-making.

PART 1: Approach to LP in Suspected Meningitis with Raised ICP

The Core Dilemma

Lumbar puncture (LP) is essential to diagnose meningitis — but herniation is a real risk if ICP is significantly raised. However, antibiotics must not be delayed waiting for imaging or LP.
"Antibiotics should not be delayed awaiting successful lumbar puncture. Antibiotics will not affect PCR or bacterial antigen testing." — Rosen's Emergency Medicine

Step 1 — Start Empirical Treatment IMMEDIATELY

Before any imaging or LP:
DrugDoseTarget
Ceftriaxone2 g IV q12hS. pneumoniae, N. meningitidis, H. influenzae
Vancomycin40–60 mg/kg/day ÷ q8–12hResistant pneumococcus
Ampicillin2 g IV q4hAdd if age >50, immunocompromised, or Listeria suspected
Dexamethasone0.15 mg/kg q6h × 4 daysStart with or just before first antibiotic dose → reduces mortality and neurological sequelae in pneumococcal meningitis
Aciclovir10 mg/kg IV q8hIf HSV encephalitis cannot be excluded
If blood cultures can be drawn within 10 minutes — do so before antibiotics. If not feasible, give antibiotics first.

Step 2 — Identify Features of Raised ICP / Risk of Herniation

Perform CT brain BEFORE LP if ANY of the following are present:
FeatureWhy Dangerous
Papilloedema on fundoscopyConfirms raised ICP
New focal neurological deficitSuggests mass lesion
Depressed consciousness (GCS ≤12)Impaired autoregulation
Seizure within last 1 weekMay indicate focal lesion
Immunocompromised state (HIV, transplant, steroids)Atypical mass lesion (toxoplasmosis, lymphoma)
Known CNS lesion / SOLObvious
Abnormal posturing / decerebrateImpending herniation
If NONE of the above → LP is safe without prior CT.

Step 3 — Performing the LP Safely When ICP is Raised

If CT shows:
  • No midline shift, no mass lesion, no herniation → LP can proceed, but with precautions
  • Signs of herniation / large mass / obliterated cisterns → LP is contraindicated (see alternative CSF collection below)

Safe LP Technique When ICP is Elevated:

  1. Position: Lateral decubitus (left lateral) — never sitting position when ICP is raised (sitting raises CSF pressure further at lumbar level)
  2. Needle: Use a pencil-point (atraumatic) spinal needle (Whitacre 22G) — lower risk of post-LP herniation than cutting needle; smaller bore
  3. Level: L3–L4 or L4–L5 interspace (below the conus at L1–L2)
  4. Stylet IN: Always remove stylet slowly, never rapidly decompress
  5. Measure opening pressure: Normal <20 cm H₂O; in meningitis often 20–40+ cm H₂O
  6. Volume removed: Collect minimum volume necessary (3–4 tubes, ~8–12 mL total) — do not open tap and let CSF drain freely
  7. Do NOT drain large volumes — risk of downward herniation
  8. Mannitol cover: If opening pressure >40 cm H₂O or patient deteriorates during LP:
    • Stop immediately
    • Give Mannitol 0.5–1 g/kg IV over 20 minutes
    • Consider neurosurgical consult for EVD
  9. After LP: Keep patient flat for 1 hour; monitor closely for signs of coning (Cushing's triad — hypertension, bradycardia, irregular respirations)

Step 4 — Managing ICP in Meningitis (Adjunctive Measures)

InterventionIndication / Details
Head elevation 30°Reduces ICP while maintaining cerebral perfusion
Mannitol 20% (0.5–1 g/kg IV)Acute ICP rise; osmotic diuresis; duration 3–4 hours
Hypertonic saline (3%)Alternative to mannitol; preferred in hypovolemic patients
Avoid hypotonic fluidsUse isotonic NS for maintenance
Hyperventilation (PCO₂ 30–35 mmHg)Temporary bridge only; vasoconstriction reduces CBF
DexamethasoneReduces cerebral oedema in bacterial meningitis
Avoid hyperthermiaFever worsens ICP; paracetamol/cooling
Avoid hyponatraemiaSIADH common in meningitis; fluid restriction if Na falls
External ventricular drain (EVD)If obstructive hydrocephalus develops; provides ICP monitoring + CSF drainage

When LP is Absolutely Contraindicated in Meningitis

ConditionAction
CT shows transtentorial herniation / uncal herniationNO LP; treat ICP; consider EVD
Posterior fossa mass / cerebellar herniation riskNO LP (most dangerous)
Overlying skin infection at LP siteAvoid direct LP; consider C1–C2 lateral cervical puncture by neurosurgeon
Thrombocytopenia < 20,000 or coagulopathy (INR >1.5)Correct first; or obtain CSF from EVD if already in situ

PART 2: CSF Collection in Large / Obstructive Hydrocephalus

When LP is contraindicated (obstructive hydrocephalus with high ICP), CSF must be obtained by alternative routes. This requires neurosurgical input.

Option 1 — External Ventricular Drain (EVD) / Ventriculostomy

Method of choice in acute obstructive hydrocephalus with meningitis.
  • Kocher's point (most common site): 1 cm anterior to the coronal suture, 2–3 cm lateral to midline (mid-pupillary line) on the non-dominant side
  • Catheter placed into the frontal horn of the lateral ventricle
  • Provides:
    1. Direct CSF sampling (ventricular CSF in meningitis) — highest diagnostic yield
    2. Continuous ICP monitoring
    3. Therapeutic CSF drainage to control ICP
  • Note: ventricular CSF in meningitis may show higher cell counts, lower glucose, higher protein than lumbar CSF — interpret accordingly

Option 2 — Sampling Via Existing VP Shunt / Reservoir

If the patient already has a ventriculoperitoneal (VP) shunt or Ommaya reservoir:
  • Shunt tap (by neurosurgeon or trained neurologist):
    • Insert 23–25G butterfly needle into the shunt reservoir under sterile conditions
    • Aspirate 2–3 mL CSF gently (do not aspirate hard — risk of pulling choroid plexus)
    • Send for cell count, protein, glucose, culture, sensitivity
    • Also culture the shunt hardware itself if shunt infection suspected
    • The shunt itself may be the source of infection (S. epidermidis, S. aureus — shunt meningitis)

Option 3 — C1–C2 Lateral Cervical Puncture (Cisternal Puncture)

  • Performed under fluoroscopic guidance between C1 and C2 vertebrae
  • Accesses the lateral cervical subarachnoid space
  • Used when:
    • LP site infected / impossible
    • Communicating hydrocephalus but lumbar route blocked
    • Requires experienced operator (neurosurgery/interventional radiology)

Option 4 — Cisternal Puncture (Suboccipital)

  • Needle inserted into the cisterna magna (suboccipital approach)
  • Access between the posterior arch of C1 and the foramen magnum
  • Rarely used; significant risk of brainstem injury if not performed by an expert
  • Reserved for special circumstances (lumbar block, spinal deformity)

Summary Flowchart

Suspected Meningitis
        |
        ↓
IMMEDIATELY: Blood cultures + empirical antibiotics + dexamethasone + aciclovir
        |
        ↓
Any risk features for raised ICP?
(focal signs, papilloedema, GCS≤12, immunocompromised, seizure)
        |
   YES  |   NO
        |         → LP immediately (lateral decubitus, thin needle, minimal volume)
        ↓
CT Brain STAT
        |
   No herniation   →   LP with ICP precautions
        |
   Herniation / obstructive hydrocephalus
        |
        ↓
NEUROSURGERY: EVD / shunt tap / Ommaya reservoir
        ↓
Ventricular CSF sent for analysis + culture
ICP controlled with EVD drainage

Sources: Bradley and Daroff's Neurology in Clinical Practice; Rosen's Emergency Medicine 10E; Harrison's Principles of Internal Medicine 22E

Peripheral vertigo vs central vertigo

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Rich, authoritative content from multiple sources. Now compiling the complete comparison.

Peripheral Vertigo vs. Central Vertigo


Anatomy in Brief

PeripheralCentral
Lesion siteLabyrinth (inner ear) or VIII cranial nerve (up to root entry zone)Brainstem (vestibular nuclei) or cerebellum or their connections
Common structuresSemicircular canals, utricle, saccule, vestibular nerveLateral medulla, pons, cerebellum, 4th ventricle

Master Comparison Table

FeaturePeripheralCentral
OnsetSudden, abruptGradual or sudden (sudden in stroke)
Severity of vertigoSevere, intense rotational sensationMild to moderate (can be severe in hemorrhage/stroke)
DurationBPPV: seconds (<1 min); Neuritis: hours to daysTIA: minutes; others: weeks to months (continuous)
FatigabilityYes — diminishes with repeated positioning (BPPV)No — persistent, non-fatigable
Effect of head positionStrongly positional (BPPV); aggravated by movementUsually little change with position
Nausea/vomitingSevere, prominentVariable, often milder
Imbalance / gaitMild–moderate; patient can stand; veers toward lesion sideSevere; patient often cannot stand or walk without support
Nystagmus directionUnidirectional — fixed fast phase direction; horizontal ± torsionalDirection-changing on lateral gaze; may be purely vertical or purely torsional
Fixation effectSuppressed by visual fixationNot suppressed by fixation
Latency after positioning2–20 secondsBrief / immediate
HabituationYes — fatigues with repeat maneuversNo
Hearing loss / tinnitusPresent in labyrinthitis, Ménière diseaseRare (except in AICA infarction)
Neurological signsAbsentUsually present — dysarthria, dysphagia, diplopia, facial numbness, limb ataxia, weakness
Head impulse testPositive (corrective saccade — vestibular nerve dysfunction)Negative (eyes hold fixation — central compensation)
RecoveryRapid (days–weeks with vestibular neuritis)Slow

Nystagmus — The Key Discriminator

"Spontaneous nystagmus of peripheral origin is typically horizontal or horizontal-torsional and does not change direction with gaze. Spontaneous nystagmus of central origin can be purely vertical or torsional and usually changes direction with changes in gaze." — Cummings Otolaryngology
Nystagmus FeaturePeripheralCentral
DirectionHorizontal ± torsional (mixed)Purely vertical, purely torsional, or direction-changing
Direction change with gazeNo — always beats to same side regardless of gazeYes — changes direction with direction of gaze
FixationSuppressed (Alexander's law)Not suppressed (persists with fixation)
Latency on Dix-Hallpike2–20 secondsImmediate / no latency
Fatigability on repeat testingYesNo
Purely downbeating nystagmusNeverCentral (cervicomedullary junction, Arnold-Chiari)
Purely upbeating nystagmusNeverCentral (brainstem)
See-saw nystagmusNeverCentral (parasellar, midbrain)

The HINTS Exam (Bedside — For Acute Vestibular Syndrome)

Used specifically in patients with constant (not positional) acute vertigo — distinguishes posterior circulation stroke from vestibular neuritis.
ComponentPeripheral (Reassuring)Central (Alarming)
H — Head Impulse TestPositive (corrective catch-up saccade)Negative (no saccade — eyes stay fixed)
IN — NystagmusUnidirectional, horizontalDirection-changing with lateral gaze
TS — Test of SkewAbsent skew deviationPresent vertical skew (ocular misalignment on cover test)
HINTS positive for central = negative HIT + direction-changing nystagmus + skew deviation → stroke until proven otherwise → MRI DWI urgently
⚠️ HINTS should only be used in acute vestibular syndrome (constant vertigo); not valid in BPPV. Requires experienced examiner.

Causes

Peripheral Vertigo Causes

ConditionKey Features
BPPV (most common overall)Brief (<1 min), positional, posterior semicircular canal; positive Dix-Hallpike → upbeat + torsional nystagmus; treat with Epley maneuver
Vestibular neuritisAcute severe sustained vertigo, hours to days; post-viral; no hearing loss; positive HIT; spontaneous horizontal nystagmus beating away from lesion
LabyrinthitisSame as neuritis + hearing loss (cochlear involvement)
Ménière diseaseTriad: recurrent episodic vertigo (hours) + unilateral sensorineural hearing loss + tinnitus ± ear fullness; endolymphatic hydrops
Perilymphatic fistulaPost-Valsalva / trauma; pressure-related vertigo
Acoustic neuroma (vestibular schwannoma)Progressive unilateral hearing loss + vertigo; VIII nerve
Otosclerosis, chronic otitisMiddle ear disease with vestibular involvement
Drug toxicityAminoglycosides, cisplatin, furosemide — ototoxic

Central Vertigo Causes

ConditionKey Features
Vertebrobasilar TIA/strokeElderly + atherosclerosis; vertigo + neurological symptoms; HINTS negative HIT; MRI DWI
Wallenberg syndrome (PICA infarction)Vertigo + ipsilateral facial numbness + contralateral body pain/temp loss + dysphagia + Horner's + ataxia
AICA infarctionVertigo + ipsilateral hearing loss + facial palsy + cerebellar signs
Cerebellar hemorrhageSudden severe vertigo + headache + vomiting + inability to stand; emergency (decompression needed)
Multiple sclerosisYoung adult; vertigo from demyelinating plaque in vestibular nuclei; INO often present
Vestibular migraineMost common central cause overall; recurrent vertigo with migrainous features; no fixed neurological signs
Brainstem tumorProgressive; associated cranial nerve palsies
Posterior fossa tumorsMedulloblastoma, ependymoma — children; vertigo + papilloedema
Arnold-Chiari malformationDownbeat nystagmus; neck-position-related
Wernicke's encephalopathyTriad: vertigo/ataxia + confusion + ophthalmoplegia; thiamine deficiency

Dix-Hallpike Test (Peripheral vs. Central Positional Vertigo)

FeaturePeripheral (BPPV)Central Positional
Latency2–20 secondsImmediate / none
NystagmusUpbeat + torsional (toward lower ear)Variable, any direction
Duration<60 seconds, stops spontaneouslyPersists >60 seconds
Fatigues on repeatYesNo
Patient subjective vertigoSevere, matches nystagmusMay be mild despite nystagmus

Clinical Danger Signs — "This is Central Until Proven Otherwise"

Red FlagThink
Negative head impulse test in acute continuous vertigoPosterior fossa stroke
Direction-changing nystagmusCerebellar/brainstem
Purely vertical nystagmus (downbeat or upbeat)Central (never peripheral)
Severe truncal ataxia — cannot walk at allCerebellar stroke/hemorrhage
Vertical skew deviationBrainstem
New neurological symptoms: diplopia, dysarthria, dysphagia, facial numbness, limb weaknessPosterior circulation
Sudden onset severe headache + vertigoCerebellar hemorrhage → CT STAT
Hearing loss + ipsilateral facial palsy + vertigoAICA infarction
Known vascular risk factors (age, hypertension, DM, smoker)Vertebrobasilar disease

Summary Mnemonic: "CENTRAL is DANGEROUS"

PeripheralCentral
NystagmusUnidirectionalDirection-changing
AtaxiaMildAble to walk? No
Neurological signsNonePresent
Gaze suppressionGone (fixation suppresses)Remains despite fixation
Ear symptomsPresent (hearing loss, tinnitus)Absent
RecoveryRapidOften slow
OnsetOften positionalUnprovoked or continuous
Urge to treatEpley, betahistineSurgery, thrombolysis, steroids

Sources: Rosen's Emergency Medicine 10E; Cummings Otolaryngology 7E; Adams and Victor's Principles of Neurology 12E

Convulsive status epilepticus vs non Convulsive status epilepticus crisp

Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Excellent content. I now have comprehensive material for a crisp comparison.

Convulsive vs. Non-Convulsive Status Epilepticus


Definition

Status Epilepticus (SE) = seizure activity lasting ≥5 minutes OR ≥2 seizures without recovery of consciousness between them.
Two operational time points (ILAE):
  • t1 (5 min) = treat now (abnormal, self-termination unlikely)
  • t2 (30 min) = long-term neuronal injury begins

Master Comparison Table

FeatureConvulsive SE (CSE)Non-Convulsive SE (NCSE)
DefinitionContinuous or repetitive tonic-clonic motor activity ≥5 min with impaired consciousnessElectrographic seizure activity ≥30 min with altered behavior/cognition but no prominent motor activity
ConsciousnessLost — unresponsiveAltered but variable — confusion, staring, automatisms; may appear awake
Motor featuresProminent — tonic-clonic jerking, rigidityAbsent or minimal — subtle twitching, eye deviation, facial myoclonus only
VisibilityObvious — cannot miss itOccult — easily missed; "encephalopathy" in disguise
EEG necessityConfirms and monitors; clinical diagnosis possibleEEG is mandatory — cannot diagnose without it
UrgencyImmediate life-threatening emergencyAlso emergency, but NCSE with coma is particularly resistant and deadly
Mortality~20%NCSE without coma: lower; NCSE with coma: ~50–60%
PrognosisBad if delayed; better if treated earlyWorse overall — diagnosis delayed, treatment less effective
Systemic effectsSevere — hyperthermia, acidosis, rhabdomyolysis, aspirationMilder systemic effects; neuronal injury still occurs

Types (ILAE Classification)

Convulsive SE

  • Generalized tonic-clonic SE — most dangerous; bilateral motor activity + LOC
  • Focal motor SE (including epilepsia partialis continua) — unilateral jerking; consciousness may be preserved
  • Tonic SE — sustained stiffening; often in Lennox-Gastaut
  • Myoclonic SE with coma — post-anoxic; very poor prognosis

Non-Convulsive SE

TypeConsciousnessBehaviorSetting
Absence SE (generalized)Present but slowedStaring, slow responses, unresponsive to complex commandsChildhood/adolescence; classic EEG 3 Hz spike-wave
Focal NCSE with impaired consciousnessImpairedAutomatisms, confusion, cycling fluctuationsTemporal lobe origin most common
Focal NCSE without impaired consciousness (aura continua)IntactSensory/psychic symptoms onlyPatient aware throughout
NCSE with comaAbsentComatose; subtle signs only (eye deviation, small twitches)Post-CSE, post-anoxia, ICU patients; worst prognosis

EEG Patterns

SE TypeEEG Pattern
Active CSEContinuous high-voltage rhythmic discharge
Subtle CSE (late)Periodic discharges on flat background — most dangerous stage; motor activity may have ceased but brain still seizing
Absence SEContinuous or near-continuous 3 Hz generalized spike-and-wave
Focal NCSERhythmic focal ictal discharges; may wax and wane
NCSE with comaContinuous or nearly continuous epileptiform activity; diagnosis requires clinical–EEG correlation + therapeutic trial
"The definitive diagnosis of NCSE requires EEG confirmation. Even CSE must be differentiated from psychogenic status epilepticus, which may require video-EEG." — Bradley and Daroff's
"8% of comatose patients in the ICU are found to be in NCSE — continuous EEG monitoring is essential." — Plum and Posner

Clinical Clues to NCSE

Always suspect NCSE when:
  • Prolonged postictal confusion (>30–60 min after apparent seizure cessation)
  • Unexplained altered consciousness / encephalopathy in ICU
  • Coma of unknown cause
  • Subtle motor signs: eye deviation, repetitive eye blinking, facial twitching, subtle limb myoclonus
  • "Waxing and waning" consciousness
  • Known epilepsy with unexplained behavioural change
  • Failure to regain consciousness after treatment of CSE → suspect subtle CSE / NCSE with coma

Treatment Protocol

Phase 1 — Stabilization (0–5 min)

  • ABC, IV access, O₂, glucose check (give 50 mL 50% dextrose if low + thiamine 100 mg IV)
  • Vital signs, cardiac monitor

Phase 2 — Initial Therapy (5–20 min) — Benzodiazepines

DrugDoseRoute
Lorazepam0.1 mg/kg IV (max 4 mg; repeat × 1)IV (preferred)
Midazolam0.2 mg/kg IM (max 10 mg)IM (if no IV access — equally effective)
Diazepam0.15 mg/kg IV OR 0.2 mg/kg rectalIV or rectal
Lorazepam 0.1 mg/kg IV controls CSE in 64.9% of cases within 20 min (VA Cooperative Study)

Phase 3 — Second-Line Agents (20–40 min, if benzodiazepines fail)

DrugDose
Levetiracetam60 mg/kg IV (max 4500 mg) over 10 min
Valproate40 mg/kg IV (max 3000 mg) over 10 min
Fosphenytoin20 mg/kg PE IV at 150 mg PE/min
Phenobarbital15 mg/kg IV at 60 mg/min
(ESETT trial 2019: levetiracetam, fosphenytoin, and valproate equally effective as second-line agents ~47% each)

Phase 4 — Refractory SE (>40 min, failed 2 agents)

Requires ICU, intubation, continuous EEG monitoring:
  • Midazolam infusion 0.2 mg/kg bolus → 0.05–2 mg/kg/h
  • Propofol 2 mg/kg bolus → 5–10 mg/kg/h (caution: propofol infusion syndrome)
  • Thiopental/pentobarbital coma — burst-suppression target

Phase 5 — Super-Refractory SE (>24 h on anaesthetic infusion)

  • Ketamine infusion
  • Inhaled isoflurane
  • Immunotherapy (steroids, IVIG, plasmapheresis — if autoimmune encephalitis suspected)
  • Ketogenic diet
  • Therapeutic hypothermia

Key Differences — Crisp Summary

CSENCSE
DiagnosisClinicalEEG mandatory
VisibilityObviousHidden — easily confused with encephalopathy
Motor activityProminentMinimal/absent
ICU prevalencePresents acutely8% of unexplained coma
NCSE with comaN/AWorst prognosis; post-anoxic, post-CSE
Treatment responseBetter to benzodiazepines (65%)Poorer, especially with coma (18%)
Systemic complicationsSevere (acidosis, rhabdomyolysis, hyperthermia)Less systemic; neuronal injury ongoing
EEG monitoring after CSE treatmentRecommendedMandatory

Sources: Bradley and Daroff's Neurology in Clinical Practice; Plum and Posner's Diagnosis and Treatment of Stupor and Coma; Harrison's Principles of Internal Medicine 22E

Cryptococal meningitis crisp and diagnosis and rx details

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Loading Image
Comprehensive data collected. Here is the crisp, complete answer.

Cryptococcal Meningitis


Organism & Epidemiology

  • Cryptococcus neoformans — encapsulated basidiomycete yeast; C. gattii in immunocompetent hosts
  • Ubiquitous in soil, pigeon droppings; inhalation → primary pulmonary infection → haematogenous spread to CNS
  • Most common AIDS-defining meningitis globally; most common cause of adult meningitis in Sub-Saharan Africa
  • Occurs when CD4+ count <100 cells/μL in HIV; also affects transplant recipients, haematologic malignancies, high-dose steroids
  • Universally fatal if untreated

Pathophysiology

The polysaccharide capsule:
  • Inhibits phagocytosis
  • Reduces inflammation → CSF often has surprisingly few cells (minimal pleocytosis)
  • Accumulates in Virchow-Robin spaces → gelatinous pseudocysts in basal ganglia
  • Blocks CSF resorption → raised ICP — the primary cause of death and neurological damage

Clinical Features

FeatureDetail
HeadacheMost common presenting symptom; progressive, severe
FeverOften low-grade or absent
MeningismPresent in only ~50% — often ABSENT, especially in HIV
Altered consciousnessConfusion, personality change, cognitive impairment
Cranial nerve palsiesII (vision), VI, VII — from raised ICP or basilar involvement
PhotophobiaPresent
PapilloedemaRaised ICP
SeizuresLess common
ComaLate/severe disease
⚠️ Classic meningeal signs may be absent in >50% of immunocompromised patients. Think cryptococcal meningitis in any HIV patient with headache.

MRI Brain

Cryptococcal Meningitis MRI — Gelatinous pseudocysts in basal ganglia (arrows)
Axial T2 MRI: bilateral gelatinous pseudocysts in basal ganglia — characteristic of cryptococcal meningitis in AIDS
Other MRI findings: hydrocephalus, infarction, cryptococcoma (focal mass), cerebral atrophy

Diagnosis

CSF Analysis — Key Tests

TestSensitivity (HIV)Sensitivity (non-HIV)Notes
Cryptococcal antigen (CrAg) — CSF~100%86–95%Rapid, specific; test of choice
India ink82%~50%Positive = characteristic halo around encapsulated yeast
Fungal culture100%~90%Gold standard but takes weeks
Gram stainLowerWeakly Gram-positive; often not visualised
Serum CrAg~100%Excellent screening test; use in all HIV patients with CD4 <100

CSF Biochemistry (Typical Pattern)

ParameterFinding
Opening pressureElevated (often >25 cm H₂O; may be >40)
WBCMinimal — 0–50 cells/μL (mononuclear); sometimes normal
ProteinElevated
GlucoseLow (hypoglycorrhachia)
India inkEncapsulated budding yeast with clear halo
Low CSF cell count + high antigen titre = poor prognosis (immune system not reacting)

Other Diagnostic Points

  • Lateral flow assay (LFA) — point-of-care CrAg test; rapid, cheap, field-deployable
  • β-D-glucan: NOT useful for Cryptococcus (useful for other fungi)
  • Screen all HIV patients with CD4 <100 with serum CrAg before ART initiation

Poor Prognostic Features

  • Impaired consciousness at presentation
  • Raised ICP / hydrocephalus
  • CSF CrAg titre >1:1024
  • Low CSF WBC (<20 cells/μL) — reflects poor host immune response
  • Positive India ink on CSF
  • High fungal burden
  • Mortality: 10–25% in resource-rich settings; up to 43% in resource-poor settings

Treatment

Treatment is given in three phases:

Phase 1 — Induction (2 weeks)

Preferred regimen (HIV-associated, standard care):
DrugDoseRouteDuration
Liposomal Amphotericin B3–4 mg/kg/dayIV2 weeks
+ Flucytosine (5-FC)100 mg/kg/day ÷ q6hOral2 weeks
Liposomal AmB preferred over AmB deoxycholate — less nephrotoxicity
Alternative if flucytosine unavailable:
  • AmB deoxycholate 0.7–1 mg/kg/day IV + fluconazole 800 mg/day
Monitoring during induction:
  • Daily renal function, electrolytes (K⁺, Mg²⁺) — amphotericin causes nephrotoxicity, hypokalemia, hypomagnesemia
  • FBC (flucytosine → bone marrow suppression, especially in HIV)
  • Flucytosine levels if available (target 40–60 μg/mL)

Phase 2 — Consolidation (8 weeks)

DrugDoseDuration
Fluconazole400 mg/day orally8 weeks

Phase 3 — Maintenance / Secondary Prophylaxis

DrugDoseDuration
Fluconazole200 mg/day orallyUntil CD4 >200 cells/μL sustained for ≥6 months on ART
Without maintenance therapy → relapse in >50% of patients

Management of Raised ICP (Critical)

Raised ICP is the primary cause of early death in cryptococcal meningitis. Management is active and mandatory.
InterventionDetail
Measure opening pressure at every LPTreat if >25 cm H₂O
Therapeutic LP (repeated)Remove 20–30 mL CSF; repeat daily until pressure normalises; associated with improved survival (COAT trial)
Lumbar drainIf daily LPs are not sufficient
VP shuntIf LP contraindicated or severe refractory hydrocephalus
AcetazolamideMay help as adjunct
Optic nerve sheath fenestrationIf visual loss from raised ICP
CorticosteroidsNOT routinely recommended — no benefit and possible harm in cryptococcal meningitis (unlike bacterial meningitis)
MannitolNot effective for chronic raised ICP in this setting

ART Timing in HIV (Critical — COAT Trial)

Starting ART within 1–2 weeks of beginning antifungal therapy increased 26-week mortality to 45% vs. 30% if ART delayed to 5 weeks (HR 1.73; COAT trial 2014)
Rule: Delay ART by ≥5 weeks after starting antifungal induction in newly diagnosed cryptococcal meningitis — avoids Immune Reconstitution Inflammatory Syndrome (IRIS).

IRIS in Cryptococcal Meningitis

  • Occurs weeks to months after ART initiation as CD4 count recovers
  • Paradoxical worsening of symptoms (headache, fever, lymphadenopathy, neurological deterioration)
  • Treat with corticosteroids (dexamethasone or prednisolone) + continued antifungals
  • Do not stop ART

Diagnostic Sensitivity Summary

TestAIDSNon-AIDS
CrAg (CSF/serum)~100%86–95%
India ink82%50%
Culture100%90%

Crisp Summary

Cryptococcal Meningitis
     │
     ├── Who: HIV (CD4 <100), transplant, steroids
     ├── Organism: C. neoformans (encapsulated yeast)
     ├── Classic: headache + raised ICP ± minimal meningism
     ├── Diagnose: CSF CrAg (>90%) + India ink + culture
     │
     ├── TREAT:
     │   Induction (2 wks): Liposomal AmB 3–4 mg/kg/day + Flucytosine 100 mg/kg/day
     │   Consolidation (8 wks): Fluconazole 400 mg/day
     │   Maintenance: Fluconazole 200 mg/day until CD4 >200 × 6 months
     │
     ├── ICP: Daily therapeutic LPs → target normal pressure
     ├── ART: Delay ≥5 weeks (COAT trial)
     └── Mortality: 10–43% despite treatment
Sources: Bradley and Daroff's Neurology in Clinical Practice; Medical Microbiology 9E; Goldman-Cecil Medicine; Fishman's Pulmonary Diseases and Disorders

Mri basal ganglia exudates images and Differential

Finding Sources
Finding Sources
Finding Sources
Searching Images

MRI basal ganglia lesion T2 hyperintensity exudate

Searching Images

cryptococcal meningitis basal ganglia pseudocysts gelatinous MRI

Finding Sources
Loading Image
Loading Image
Searching Images

basal ganglia ring enhancing lesion toxoplasmosis abscess MRI brain

Loading Image
Loading Image
Searching Images

basal ganglia signal change Wilson disease metabolic stroke MRI bilateral

Loading Image
Loading Image
Excellent collection of images. Now compiling the comprehensive answer with images.

MRI Basal Ganglia Lesions — Images & Differential Diagnosis

The basal ganglia (caudate, putamen, globus pallidus) are metabolically active structures with rich blood supply, making them selectively vulnerable to a range of insults. The pattern of signal change on MRI is the key to narrowing the differential.

How to Approach Basal Ganglia Lesions on MRI

Ask four questions:
  1. Unilateral or bilateral?
  2. What is the signal pattern? (T2 bright, T1 bright/dark, ring enhancing, non-enhancing)
  3. Is there restricted diffusion (DWI)?
  4. Clinical context? (Age, immunocompromise, toxic exposure, metabolic disease)

Image Gallery

1. Cryptococcal Meningitis — Gelatinous Pseudocysts

Cryptococcal meningitis MRI — gelatinous pseudocysts in basal ganglia, leptomeningeal enhancement, hydrocephalus
Panels A–C: T2 hyperintense / T1 hypointense gelatinous pseudocysts in basal ganglia — NO contrast enhancement (distinguishes from abscess). Panels D–F: leptomeningeal enhancement in cerebellar gyri and basal cisterns. Panels G–H (FLAIR): hydrocephalus with periventricular transependymal CSF. Panel I: CT showing progressive ventriculomegaly.
Cryptococcal meningitis — T2 pseudocysts (b), hydrocephalus (c), pontine infarct (d), cryptococcoma (e)
Panel a: T1+Gad — basal meningeal enhancement (arrows). Panel b: T2 — hyperintense gelatinous pseudocyst in basal ganglia. Panel c: hydrocephalus. Panel d: DWI — pontine infarct (vascular complication). Panel e: T2 — cryptococcoma (solid fungal mass).

2. Cryptococcal Meningitis — Dilated Virchow-Robin Spaces (Perivascular Pseudocysts)

Cryptococcal meningitis — dilated VR spaces in basal ganglia, ventriculitis, hydrocephalus
Panel A (FLAIR): leptomeningeal enhancement. Panel B (T1+Gad): choroid plexus and ependymal enhancement (ventriculitis). Panel C (T2): punctate T2 hyperintense foci in basal ganglia — dilated Virchow-Robin spaces filled with fungal gelatinous material. Panel D: obstructive hydrocephalus with right temporal horn entrapment.

3. Cerebral Toxoplasmosis — Ring-Enhancing Lesions in Basal Ganglia

Toxoplasmosis — ring-enhancing lesions in left globus pallidus and hypothalamus with mass effect
HIV/AIDS: (a) ring-enhancing mass in left globus pallidus ~2.6×1.9 cm. (b) second lesion in hypothalamus. (c) 6 mm midline shift + obstructive hydrocephalus. Classic toxoplasmosis in advanced immunosuppression.

4. Autoimmune Encephalitis (LGI1) — T2 Shine-Through, No True Restricted Diffusion

LGI1 autoimmune encephalopathy — T2/FLAIR hyperintensity in basal ganglia without true restricted diffusion (T2 shine-through)
Panel A (FLAIR): hyperintensity in left basal ganglia (caudate + putamen swelling). Panel B (DWI): high signal. Panel C (T2): same lesion. Panel D (ADC): NO hypointensity → T2 shine-through, NOT true restricted diffusion. Key to differentiate from CJD and ischemia.

5. Wilson Disease — Bilateral Basal Ganglia T2 Signal Changes

Wilson disease — T2 MRI showing bilateral basal ganglia signal changes, face of the giant panda sign in midbrain
A: bilateral caudate, putamen, thalamus, corpus callosum splenium hyperintensity. B–C: midbrain tegmentum hyperintensity. D: T2 hypointense globus pallidus (mineral deposition) + "bright claustrum" sign. E: complex putaminal signal (central hypointense, peripheral hyperintense). F: "Face of the Giant Panda" sign in midbrain — pathognomonic of Wilson disease.

Differential Diagnosis of Basal Ganglia Lesions on MRI

Organized by signal pattern and context:

A. Bilateral Symmetric T2 Hyperintensity (Non-Enhancing)

DiagnosisKey FeaturesClue
Wilson diseaseCaudate, putamen, thalamus, midbrain; T1 hypo/hyper; "face of giant panda"Young adult; liver disease; KF rings; ↓ceruloplasmin
Carbon monoxide poisoningGlobus pallidus (bilateral symmetric T2/DWI)Exposure history; cherry-red skin
Cyanide / methanol poisoningPutamen necrosis bilaterallyToxic exposure
Leigh syndromeCaudate, putamen, brainstem; T2 brightMitochondrial disorder; children; ↑lactate
Methylmalonic / propionic acidemiaBasal ganglia bilateral T2 hyperintensityMetabolic crisis; organic acids in urine
Hypoxic-ischaemic encephalopathyPutamen, thalamus; globus pallidus; DWI brightCardiac arrest, near-drowning; raised lactate
Hepatic encephalopathyGlobus pallidus T1 hyperintensity (manganese deposition)Cirrhosis; ↑ammonia
Kernicterus (neonatal)Globus pallidus T1 brightNeonatal hyperbilirubinaemia
Osmotic demyelination (CPM)Pontine + extrapontine (BG); T2 brightRapid Na correction
CJDCaudate, putamen; DWI bright with ADC dark — TRUE restricted diffusion; "ribboning" cortexRapid dementia; 14-3-3 in CSF
NBIA (Neurodegeneration with Brain Iron Accumulation)Globus pallidus "eye of the tiger" sign — central T2 bright, surrounded by hypointense rimPantothenate kinase deficiency; young

B. Unilateral / Focal T2 Hyperintensity ± Enhancement

DiagnosisSignalEnhancementClue
Basal ganglia infarct (lenticulostriate artery)T2 bright; DWI bright + ADC darkNo enhancement (acute)Vascular risk factors; sudden onset hemiplegia
Hypertensive putaminal hemorrhageT2 hypointense (haemosiderin); heterogeneousRing or no enhancementHypertension; sudden onset
Brain abscessT2 bright cavity; DWI bright coreThick uniform ringFever; source of infection
ToxoplasmosisT2 bright; necrotic coreRing-enhancing often in BG; multipleHIV CD4 <100; multiple lesions
Primary CNS lymphomaIso-to-hypointense on T2; homogeneousSolid / homogeneous enhancement in HIVHIV; periventricular; EBV
MetastasisT2 bright; vasogenic edemaRing or solid enhancementKnown primary cancer
TuberculomaT2 hypointense (central)Ring or target enhancementTB exposure; meningeal enhancement too
NeurocysticercosisCyst with scolex; T2 brightRing enhancement around cyst; calcification (old)Endemic region; seizures

C. Non-Enhancing Punctate T2/FLAIR Bright Lesions in Basal Ganglia

DiagnosisFeature
Cryptococcal pseudocystsBilateral; follow CSF signal; NO enhancement; dilated perivascular spaces
Dilated perivascular spaces (normal variant)Tiny, symmetrical; follow CSF on all sequences; no DWI restriction
Lacunar infarctsSmall; FLAIR bright rim; old = hypointense center; vascular risk factors
MS plaquesLess common in BG; other typical demyelinating lesions elsewhere

D. Autoimmune / Inflammatory

DiagnosisKey Feature
LGI1 autoimmune encephalitisUnilateral/bilateral BG T2 bright; faciobrachial dystonic seizures; no true DWI restriction (T2 shine-through)
NMDAR encephalitisBG/limbic involvement; cortical FLAIR changes; psychiatric onset
Rasmussen encephalitisUnilateral progressive atrophy + signal; children
Susac syndromeCorpus callosum "snowballs" + BG lesions + sensorineural deafness
ADEMBilateral BG T2 lesions; post-infectious; demyelinating pattern
Behçet diseaseBrainstem + BG involvement; parenchymal neuro-Behçet

Key Discriminating Points

PatternTop Diagnoses
Bilateral BG T2 bright + metabolic contextWilson, CO, Leigh, HIE, hepatic encephalopathy
Bilateral BG DWI bright + ADC darkCJD, HIE
Bilateral BG T2 bright + T2 shine-through (ADC normal)Autoimmune encephalitis (LGI1)
Globus pallidus T1 brightHepatic encephalopathy (Mn), CO (subacute), NF1
Globus pallidus "eye of the tiger"PKAN (NBIA)
Punctate BG + follow CSF + no enhancementCryptococcal pseudocysts
Ring-enhancing BG in HIVToxoplasmosis (multiple) vs. PCNSL (single, solid)
Basal ganglia + meningeal enhancement + hydrocephalusCryptococcal, TB, bacterial meningitis

Sources: Bradley and Daroff's Neurology in Clinical Practice; Medical Microbiology 9E; Goldman-Cecil Medicine; Grainger & Allison's Diagnostic Radiology

Mri of basal exudates with image and Differential

Searching Images

MRI basal cistern exudates meningitis T1 enhancement tuberculosis

Finding Sources
Loading Image
Loading Image
Searching Images

basal meningitis MRI cryptococcal fungal leptomeningeal enhancement cistern

Loading Image
Loading Image
Searching Images

sarcoidosis neurosarcoidosis leptomeningeal enhancement MRI basal cistern

Loading Image
Loading Image
Finding Sources
Reading File
Searching Images

leptomeningeal carcinomatosis MRI enhancement basal cistern sulci

Loading Image
Loading Image
Now composing the full, image-rich answer on basal cistern exudates.

MRI Basal Cistern Exudates — Images & Differential Diagnosis

Basal cistern exudates = pathological material (pus, fibrin, granulomas, tumour cells, fungal elements) filling the cisterns at the base of the brain — the interpeduncular cistern, prepontine cistern, suprasellar cistern, ambient cisterns, and cisterna magna.
On MRI with gadolinium, this appears as abnormal enhancement, T1 hyperintensity, or FLAIR hyperintensity filling and obliterating the normally dark (CSF-filled) basal cisterns.

Normal vs. Abnormal Basal Cisterns

NormalAbnormal (Exudate)
T1 + contrastNo enhancement; CSF darkBright enhancement filling cisterns
FLAIRCSF completely suppressed (black)Hyperintense — CSF suppression fails
Cistern morphologyPatent, openObliterated, filled with material

Image Gallery

1. Tuberculous Meningitis — Thick Basal Cistern Enhancement (Classic)

Tuberculous meningitis — diffuse thick leptomeningeal enhancement in basal cisterns and Sylvian fissures; hydrocephalus on coronal view
Left (axial T1+Gad): dense enhancement surrounding the brainstem and interpeduncular cistern — the hallmark of TB meningitis. Right (coronal T1+Gad): enhancement in Sylvian fissures + basal surfaces + secondary hydrocephalus (ventriculomegaly) from cistern obliteration.

2. TBM — Axial T1+Gad — Interpeduncular Cistern Obliteration

Tuberculous meningitis — T1+Gad axial showing bright enhancement in interpeduncular cistern (arrow)
Intense bright enhancement filling the interpeduncular / prepontine cistern (arrow). The surrounding brain parenchyma is relatively preserved. This is the canonical "basal exudate" appearance in TB.

3. TB Meningitis — Radiological Triad (Hydrocephalus + Basal Enhancement + Pachymeningitis)

TBM — coronal T2 showing hydrocephalus; sagittal T2 showing 3rd ventricle dilatation; axial T1+Gad showing basal cistern and pachymeningeal enhancement
Left (coronal T2): ventriculomegaly. Middle (sagittal T2): dilated 3rd + 4th ventricles — communicating hydrocephalus. Right (axial T1 FATSAT+C): pachymeningeal enhancement right hemisphere (white arrow) + basal cistern enhancement (blue arrow). The MRI triad of TBM: hydrocephalus + basal cistern enhancement + pachymeningitis.

4. TBM — Active Basal Exudates Then Steroid Response (Sequential)

TBM sequential MRI — active basal exudates at day 60, T2 edema, then gradual resolution with steroids at day 75 and 90
Panel a (T1+Gad, day 60): intense basal leptomeningeal enhancement + parenchymal tuberculomas. Panel b (T2): extensive vasogenic edema right temporal/Sylvian. Panels c–d (T1+Gad, days 75 & 90 post-steroid): progressive resolution of enhancement. Illustrates paradoxical worsening then steroid response in neurotuberculosis.

5. Neurosarcoidosis — Nodular Leptomeningeal Enhancement at Basal Cisterns

Neurosarcoidosis — T1+Gad sagittal and axial showing leptomeningeal brainstem enhancement and nodular sarcoid deposits in superior cerebellar cistern
Panels a–b: linear enhancement along brainstem surface (white arrows) — leptomeningeal infiltration. Panels c–d: discrete nodular sarcoid deposits in superior cerebellar cistern (white arrows). Sarcoid favours basal cisterns similarly to TB but is non-caseating granuloma.

6. FLAIR Hyperintensity in Basal Cisterns (Non-specific but Sensitive)

FLAIR axial — interpeduncular cistern FLAIR hyperintensity (yellow arrows) indicating leptomeningeal inflammation — TBM or sarcoid
FLAIR sequence: failure of CSF suppression in the interpeduncular cistern (yellow arrows) — linear hyperintensity along pial surface of midbrain. FLAIR cistern hyperintensity is a sensitive early sign of basal meningitis (TBM, sarcoid, carcinomatosis). Less specific than T1+Gad but visible without contrast.

7. Leptomeningeal Carcinomatosis — "Sugar-Coating" (Zuckerguss) Appearance

Leptomeningeal carcinomatosis from medulloblastoma — sugar-coating of sulci and cisterns, ambient cistern deposit, drop metastases in lumbar spine
Panel A (sagittal T1+Gad): diffuse linear enhancement along sulci — "sugar-coating/zuckerguss" pattern; bulky deposit in ambient cistern (arrow). Panel B (axial T1+Gad): intense enhancement surrounding pons + cerebellar folia. Panel C (sagittal spine T1+Gad): drop metastasis at inferior thecal sac (arrow). Tumour cells spread via CSF pathways.

Differential Diagnosis of Basal Cistern Exudates/Enhancement

1. Infectious Causes (Most Common)

CausePattern of EnhancementKey Clinical Features
Tuberculous meningitisThick, nodular, basal predominant — interpeduncular, suprasellar, ambient cisterns + Sylvian fissures; tuberculomas; hydrocephalus; infarctsSubacute onset; fever; meningism; cranial nerve palsies (II, III, VI, VII); lymphocytic CSF, low glucose, high protein; AFB stain/culture; ADA↑
Bacterial meningitisDiffuse leptomeningeal enhancement; may be basal or convexityAcute onset; high fever; neck stiffness; neutrophilic CSF; Gram stain positive
Cryptococcal meningitisMinimal or no enhancement often; dilated VR spaces in basal ganglia; leptomeningeal enhancement when present is subtleHIV (CD4<100); headache; minimal meningism; India ink; CrAg >90%
Fungal meningitis (non-crypto) — Candida, Aspergillus, CoccidioidesEnhancement in basal cisterns; often nodular/exudativeImmunocompromised; transplant; antifungals
Neurocysticercosis (basal/cisternal type)Cysts in basal cisterns; no scolex in extraparenchymal form; enhancement of cyst wall; racemose NCC = grape-like cluster in cisternsEndemic; seizures; hydrocephalus from cyst obstructing cisterns
Pyogenic ventriculitis/ependymitisPeriventricular enhancement; extension to basal cisternsPost-neurosurgery; shunt infection; neonates
Viral meningitis/encephalitisUsually mild/no enhancement; or subtle basalHSV, CMV, enteroviruses

2. Granulomatous / Inflammatory (Non-Infectious)

CausePatternKey Features
NeurosarcoidosisNodular, linear leptomeningeal enhancement; basal cisterns + cranial nerves + hypothalamus + pituitary stalkYoung adults; bilateral hilar adenopathy; ACE↑; non-caseating granuloma
Wegener's granulomatosis (GPA)Pachymeningeal or leptomeningeal enhancementSinus + lung + kidney; p-ANCA
Behçet diseaseBrainstem involvement; meningeal enhancementOrogenital ulcers, uveitis
IgG4-related diseasePachymeningeal (dural) thickening + enhancementHypophysitis; raised IgG4
Vogt-Koyanagi-HaradaLeptomeningeal + uvealUveitis, vitiligo, poliosis, hearing loss

3. Neoplastic

CausePatternKey Features
Leptomeningeal carcinomatosisDiffuse "sugar-coating" — sulci + cisterns + cranial nerves; drop metastases in spineKnown primary (breast, lung, GI, melanoma, lymphoma); multiple cranial neuropathies; positive CSF cytology
Primary CNS lymphomaPeriventricular + leptomeningeal; basal cisternsImmunocompromised; EBV; homogeneous enhancement
Medulloblastoma / PNETPosterior fossa + cisterns + drop mets spineChildren; CSF cytology
Gliomatosis / glioma with CSF spreadLeptomeningeal seedingAggressive high-grade glioma

4. Vascular / Other

CausePatternKey Features
Subarachnoid hemorrhageFLAIR cistern hyperintensity (blood → CSF suppression fails); no post-Gad enhancementSudden severe headache; xanthochromia in CSF
Chemical meningitisPost-LP, post-surgery, drug-inducedHistory
Superficial siderosisT2 hypointense rim on brainstem surface (hemosiderin)Chronic; hearing loss; cerebellar ataxia

Key Discriminating Features

PatternTop Diagnosis
Thick nodular basal enhancement + hydrocephalus + cranial nerve palsiesTuberculous meningitis
Basal cistern obliteration + infarcts (lenticulostriate territory)TB meningitis (vasculitis)
Nodular deposits + brainstem + cranial nerve enhancementNeurosarcoidosis
Racemose cysts in cisternsCisternal neurocysticercosis
FLAIR bright cisterns without post-Gad enhancementSubarachnoid haemorrhage; early bacterial meningitis
Diffuse "sugar-coating" of sulci + cisterns + spinal drop metsLeptomeningeal carcinomatosis
Minimal enhancement but VR space dilation in BGCryptococcal meningitis
Thick dural/pachymeningeal > leptomeningealIgG4, meningioma en plaque, sarcoid

Pathology of TBM Basal Exudates (Adams & Victor)

"A thick, gelatinous exudate accumulates at the base of the cerebral hemispheres, obliterating the pontine and interpeduncular cisterns and extending to the meninges around the medulla, the floor of the third ventricle, the optic chiasm, and the undersurfaces of the temporal lobes... Cranial nerves are often involved far more often than with typical bacterial meningitis. Arteries may become inflamed and occluded, with infarction of brain."
This pathological description explains the classic MRI triad of TBM:
  1. Dense basal cistern enhancement
  2. Communicating hydrocephalus (cistern blockage)
  3. Cerebral infarcts (endarteritis of perforators)

Sources: Adams and Victor's Principles of Neurology 12E; Bradley and Daroff's Neurology in Clinical Practice; Grainger & Allison's Diagnostic Radiology

Rapidly progressive dementia with 1 Yr and myoclonus 4 month Differential

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
This is a shared conversation. Sign in to Orris to start your own chat.